Literature DB >> 8144304

What does the odds ratio estimate in a case-control study?

N Pearce1.   

Abstract

The use of the term 'odds ratio' in reporting the findings of case-control studies is technically correct, but is often misleading. The meaning of the odds ratio estimates obtained in a case-control study differs according to whether controls are selected from person-time at risk (the study base), persons at risk (the base-population at risk at the beginning of follow-up), or survivors (the population at risk at the end of follow-up). These three methods of control selection correspond to estimating the rate ratio, risk ratio, or the odds ratio respectively, by means of calculating the odds ratio in the subjects actually studied. None of these estimation procedures depends on any rare disease assumption. Where the rare disease assumption is relevant is whether the effect which is estimated (e.g. the odds ratio) is approximately equal to some other effect measure of interest (e.g. the risk ratio or rate ratio) in the underlying study base. To avoid confusion on this issue, authors should be encouraged to not only specify the manner in which controls have been selected (e.g. by density sampling) but also the corresponding effect measure which is being estimated (e.g. the rate ratio) by the 'odds ratio' which is obtained in a case-control analysis.

Entities:  

Mesh:

Year:  1993        PMID: 8144304     DOI: 10.1093/ije/22.6.1189

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  60 in total

1.  Epidemiology: populations, methods and theories.

Authors:  Neil Pearce
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

2.  Urologic care and progression to end-stage kidney disease: a Chronic Kidney Disease in Children (CKiD) nested case-control study.

Authors:  D I Chu; A G Abraham; G E Tasian; M R Denburg; M E Ross; S A Zderic; S L Furth
Journal:  J Pediatr Urol       Date:  2019-03-16       Impact factor: 1.830

3.  A Most Odd Ratio:: Interpreting and Describing Odds Ratios.

Authors:  Alexander Persoskie; Rebecca A Ferrer
Journal:  Am J Prev Med       Date:  2016-09-14       Impact factor: 5.043

Review 4.  Plant science and human nutrition: challenges in assessing health-promoting properties of phytochemicals.

Authors:  Maria H Traka; Richard F Mithen
Journal:  Plant Cell       Date:  2011-07-29       Impact factor: 11.277

5.  FTO gene variation, macronutrient intake and coronary heart disease risk: a gene-diet interaction analysis.

Authors:  Jaana Gustavsson; Kirsten Mehlig; Karin Leander; Christina Berg; Gianluca Tognon; Elisabeth Strandhagen; Lena Björck; Annika Rosengren; Lauren Lissner; Fredrik Nyberg
Journal:  Eur J Nutr       Date:  2015-02-03       Impact factor: 5.614

6.  Thyroid dysfunction, thyroid hormone replacement and colorectal cancer risk.

Authors:  Ben Boursi; Kevin Haynes; Ronac Mamtani; Yu-Xiao Yang
Journal:  J Natl Cancer Inst       Date:  2015-04-08       Impact factor: 13.506

7.  Variation in inflammation-related genes and risk of incident nonfatal myocardial infarction or ischemic stroke.

Authors:  Joshua C Bis; Susan R Heckbert; Nicholas L Smith; Alexander P Reiner; Kenneth Rice; Thomas Lumley; Lucia A Hindorff; Kristin D Marciante; Daniel A Enquobahrie; Stephanie A Monks; Bruce M Psaty
Journal:  Atherosclerosis       Date:  2007-11-05       Impact factor: 5.162

8.  Variation in eicosanoid genes, non-fatal myocardial infarction and ischemic stroke.

Authors:  Rozenn N Lemaitre; Kenneth Rice; Kristin Marciante; Joshua C Bis; Thomas S Lumley; Kerri L Wiggins; Nicholas L Smith; Susan R Heckbert; Bruce M Psaty
Journal:  Atherosclerosis       Date:  2008-11-01       Impact factor: 5.162

9.  Parity and risk of thyroid cancer: a nested case-control study of a nationwide Swedish cohort.

Authors:  M R Galanti; M Lambe; A Ekbom; P Sparén; B Pettersson
Journal:  Cancer Causes Control       Date:  1995-01       Impact factor: 2.506

10.  The joint effects of apolipoprotein B, apolipoprotein A1, LDL cholesterol, and HDL cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controls.

Authors:  Sarah Parish; Richard Peto; Alison Palmer; Robert Clarke; Sarah Lewington; Alison Offer; Gary Whitlock; Sarah Clark; Linda Youngman; Peter Sleight; Rory Collins
Journal:  Eur Heart J       Date:  2009-06-11       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.